Comparison of how the the clauses of 21 CFR 211.110(a) are enforced.
Subsection text:
(a) To assure batch uniformity and integrity of drug products, written procedures shall be established and followed that describe the in-process controls, and tests, or examinations to be conducted on appropriate samples of in-process materials of each batch
You must be have a paid or trial subscription to view this content
Note: We offer new accounts a one week trial to see how they can reduce costs with better regulatory intelligence.
If you already have an account or want to sign up you can do so at one of the links below
Still skeptical? No worries! Not everything is behind a paywall and you can still: